---
title: "Lite Strategy, Inc. (LITS.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/LITS.US.md"
symbol: "LITS.US"
name: "Lite Strategy, Inc."
industry: "Biotechnology"
datetime: "2026-05-20T01:58:06.896Z"
locales:
  - [en](https://longbridge.com/en/quote/LITS.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/LITS.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/LITS.US.md)
---

# Lite Strategy, Inc. (LITS.US)

## Company Overview

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [www.litestrategy.com](https://www.litestrategy.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.65 | 156 | - | - | - |
| PB | 0.70 | 62 | 4.09 | 0.52 | 0.47 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-02-13T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Hold | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.09 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/LITS.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/LITS.US/norm.md)
- [Related News](https://longbridge.com/en/quote/LITS.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/LITS.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**